Company Filing History:
Years Active: 2005
Title: Ferenc Andrási: Innovating in Pharmaceuticals from Budapest
Introduction
Ferenc Andrási, a notable inventor based in Budapest, Hungary, has made significant contributions to pharmaceutical research, particularly through his innovative work on benzodiazepine derivatives. His research focuses on developing new medication to treat various neurological and inflammatory conditions, showcasing his commitment to improving healthcare.
Latest Patents
Andrási holds a patent for "Substituted 2,3-benzodiazepine derivatives." This invention encompasses new 2,3-benzodiazepine derivatives of formula (I), isomers, and acid addition salts. The patent also includes pharmaceutical compositions containing these derivatives that are effective in treating muscle spasms, epilepsy, and neurodegenerative diseases, as well as alleviating symptoms of acute and chronic inflammatory disorders.
Career Highlights
Ferenc Andrási is associated with the Ivax Drug Research Institute, where he has contributed his expertise and passion for pharmaceutical innovation. His work has been pivotal in advancing drug research, particularly in the field of neuropharmacology, aiding in the development of therapeutic options for challenging medical conditions.
Collaborations
Throughout his career, Andrási has collaborated with esteemed professionals, including Sándor Sólyom and Gizella Ábrahám. These collaborations have enabled fruitful exchanges of ideas and expertise, thereby enhancing the scope and impact of their joint research efforts.
Conclusion
Ferenc Andrási stands out as an influential figure in the field of pharmaceutical innovations in Hungary. His patent on substituted 2,3-benzodiazepine derivatives not only demonstrates his inventive spirit but also reflects his dedication to creating effective treatments for serious medical conditions. As he continues to work within the Ivax Drug Research Institute, his contributions will likely pave the way for further advancements in pharmaceutical sciences.